Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|July 30, 2019
NLRP3 Inflammasome in Cardioprotective SignalingCoert J ZuurbierAmerican Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strainCoert J Zuurbier, Vanessa M Emons, Can InceAmerican Journal of Physiology. Heart and Circulatory Physiology|March 15, 2005
Ischemic preconditioning, insulin, and morphine all cause hexokinase redistributionCoert J Zuurbier, Otto Eerbeek, Alfred J MeijerShock (Augusta, Ga.)|December 29, 2017
Divergent Effects of Hypertonic Fluid Resuscitation on Renal Pathophysiological and Structural Parameters in Rat Model of Lower Body Ischemia/Reperfusion-Induced Sterile InflammationBulent Ergin, Coert J Zuurbier, Aysegul Kapucu, et al.Basic Research in Cardiology|May 14, 2025
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endotheliumMengnan Wang, Benedikt Preckel, Coert J Zuurbier, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|July 19, 2005
Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cellsCoert J Zuurbier, Cihan Demirci, Anneke Koeman, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2020
SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical modelsIoanna Andreadou, Robert M Bell, Hans Erik Bøtker, et al.Free Radical Biology & Medicine|January 23, 2021
Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injuryMaija Dambrova, Coert J Zuurbier, Vilmante Borutaite, et al.British Journal of Pharmacology|September 17, 2013
Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heartRianne Nederlof, Otto Eerbeek, Markus W Hollmann, et al.Cardiovascular Diabetology|March 19, 2022
Direct cardiac effects of SGLT2 inhibitorsSha Chen, Ruben Coronel, Markus W Hollmann, et al.Pageof 10